Oncimmune | Sustainability Performance
Oncimmune Holdings plc focuses on the development of immune profiling technologies for cancer detection. The company aims to provide innovative diagnostic solutions to improve early detection and treatment options.
1998
United Kingdom
11 - 50 employees
Biotechnology
$1M - 10M in revenue
Not profitable
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#4256
Overallⓘ#521
in United Kingdomⓘ#74
in BiotechnologyⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Controversy level
- Oncimmune's EarlyCDT blood test accuracy was debated in clinical settings regarding false positive rates.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
1
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.